Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ChAdOx1 nCoV-19 vaccine against COVID-19 in Brazil
ISRCTN89951424Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jun 2020
- Modality
- Small Molecules, Vaccines & Immunotherapeutics, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of ChAdOx1 nCoV-19, Meningococcal ACWY conjugate vaccine and acetaminophen in coronavirus disease 2019 (COVID-19), sponsored by University of Oxford. Started Jun 2020; status: completed.
02
Drugs
ChAdOx1 nCoV-19Meningococcal ACWY conjugate vaccineacetaminophen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN89951424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89951424.